Glenn R. Mattes is CEO & President at TFF Pharmaceuticals, Inc. (TFFP). They have made 8 open-market trades across 1 company since 2019, most recently 2022-05-16.
CIK 0001568678
3 open-market purchases totalling $197K since 2019, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TFFP | BUY | 2022-05-16 | 2022-05-17 | $4.78 | $76K | +20.2% | +5.1% | +15.0% |
| TFFP | BUY | 2021-09-16 | 2021-09-16 | $7.10 | $71K | +3.2% | -3.0% | -0.3% |
| TFFP | SELL | 2021-03-15 | 2021-03-17 | $17.04 | $852K | -19.5% | -26.9% | -32.1% |
| TFFP | SELL | 2021-02-16 | 2021-02-18 | $16.82 | $673K | -15.5% | -0.8% | -47.0% |
| TFFP | SELL | 2020-12-23 | 2020-12-29 | $15.33 | $460K | +13.5% | +8.1% | -10.8% |
| TFFP | SELL | 2020-11-10 | 2020-11-13 | $15.00 | $1.6M | -6.6% | -16.5% | +8.4% |
| TFFP | SELL | 2020-09-25 | 2021-01-20 | $17.49 | $1.5M | -17.6% | -13.7% | -43.1% |
| TFFP | BUY | 2019-10-25 | 2019-10-30 | $5.00 | $50K | +1.4% | +4.6% | +6.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.